|
STIM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.769850E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.523700E-03 |
| Normal-vs-Stage2 |
5.987800E-02 |
| Normal-vs-Stage3 |
4.349000E-01 |
| Normal-vs-Stage4 |
4.739200E-01 |
| Stage1-vs-Stage2 |
6.828600E-01 |
| Stage1-vs-Stage3 |
4.868300E-02 |
| Stage1-vs-Stage4 |
1.276840E-01 |
| Stage2-vs-Stage3 |
1.570550E-01 |
| Stage2-vs-Stage4 |
1.735830E-01 |
| Stage3-vs-Stage4 |
9.817600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.589600E-02 |
| Normal-vs-AfricanAmerican |
2.524800E-01 |
| Normal-vs-Asian |
2.264200E-02 |
| Caucasian-vs-AfricanAmerican |
9.237600E-01 |
| Caucasian-vs-Asian |
1.932030E-01 |
| AfricanAmerican-vs-Asian |
2.787600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.639900E-02 |
| Normal-vs-Female |
1.671770E-02 |
| Male-vs-Female |
7.100800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.217600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.379600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.086160E-01 |
| Normal-vs-Age(81-100Yrs) |
6.581000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.956400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.135200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.757200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.984200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.616800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.229800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.963800E-03 |
| Classical-VS-Follicular |
3.756400E-01 |
| Classical-VS-Other |
2.358200E-01 |
| Classical-VS-Normal |
2.721700E-03 |
| Tall-VS-Follicular |
1.143230E-01 |
| Tall-VS-Other |
9.984000E-01 |
| Tall-VS-Normal |
8.035400E-01 |
| Follicular-VS-Other |
5.149000E-01 |
| Follicular-VS-Normal |
1.406380E-01 |
| Other-VS-Normal |
8.903600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.672500E-02 |
| Normal-vs-N1 |
7.433200E-01 |
| N0-vs-N1 |
1.929370E-01 |
|
|
